These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19644805)

  • 1. [Subconjunctival injection of bevacizumab for treatment of corneal neovascularization after perforating keratoplasty].
    Maier MM; Erben A; Khoramnia R; Zapp D; Winkler von Mohrenfels C; Lohmann C
    Klin Monbl Augenheilkd; 2009 Jul; 226(7):573-5. PubMed ID: 19644805
    [No Abstract]   [Full Text] [Related]  

  • 2. Subconjunctival bevacizumab for vascularized rejected corneal grafts.
    Awadein A
    J Cataract Refract Surg; 2007 Nov; 33(11):1991-3. PubMed ID: 17964413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subconjunctival bevacizumab for corneal neovascularization.
    Doctor PP; Bhat PV; Foster CS
    Cornea; 2008 Oct; 27(9):992-5. PubMed ID: 18812760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effect of subconjunctival injection of bevacizumab in the treatment of corneal neovascularization.
    You IC; Kang IS; Lee SH; Yoon KC
    Acta Ophthalmol; 2009 Sep; 87(6):653-8. PubMed ID: 19021596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perilimbal bevacizumab injection for interface neovascularization after deep anterior lamellar keratoplasty.
    Foroutan A; Fariba B; Pejman B; Mahmoud J; Khalil GF; Arash EA; Foroutan P
    Cornea; 2010 Nov; 29(11):1268-72. PubMed ID: 20802316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Subconjunctival bevacizumab for corneal neovascularization].
    Gueudry J; Richez F; Tougeron-Brousseau B; Genevois O; Muraine M
    J Fr Ophtalmol; 2010 Nov; 33(9):630-6. PubMed ID: 21035899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subconjunctival bevacizumab for corneal neovascularization.
    Zaki AA; Farid SF
    Acta Ophthalmol; 2010 Dec; 88(8):868-71. PubMed ID: 19519730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of subconjunctival bevacizumab on corneal neovascularization: results of a prospective study.
    Benayoun Y; Adenis JP; Casse G; Forte R; Robert PY
    Cornea; 2012 Aug; 31(8):937-44. PubMed ID: 22357391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined use of superficial keratectomy and subconjunctival bevacizumab injection for corneal neovascularization.
    Qian CX; Bahar I; Levinger E; Rootman D
    Cornea; 2008 Oct; 27(9):1090-2. PubMed ID: 18812781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subconjunctival and intracorneal bevacizumab injection for corneal neovascularization in lipid keratopathy.
    Oh JY; Kim MK; Wee WR
    Cornea; 2009 Oct; 28(9):1070-3. PubMed ID: 19724199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subconjunctival bevacizumab injection for corneal neovascularization in recurrent pterygium.
    Bahar I; Kaiserman I; McAllum P; Rootman D; Slomovic A
    Curr Eye Res; 2008 Jan; 33(1):23-8. PubMed ID: 18214740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined use of subconjunctival and intracorneal bevacizumab injection for corneal neovascularization.
    Yeung SN; Lichtinger A; Kim P; Amiran MD; Slomovic AR
    Cornea; 2011 Oct; 30(10):1110-4. PubMed ID: 21673570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention and treatment of corneal neovascularization: comparison of different doses of subconjunctival bevacizumab with corticosteroid in experimental rats.
    Hashemian MN; Moghimi S; Kiumehr S; Riazi M; Amoli FA
    Ophthalmic Res; 2009; 42(2):90-5. PubMed ID: 19546599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bevacizumab for graft rejection.
    Harooni H; Reddy V; Root T; Ambati B
    Ophthalmology; 2007 Oct; 114(10):1950. PubMed ID: 17908597
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of subconjunctival and intraocular bevacizumab injections on corneal neovascularization in a mouse model.
    Avisar I; Weinberger D; Kremer I
    Curr Eye Res; 2010 Feb; 35(2):108-15. PubMed ID: 20136420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corneal graft surgery combined with subconjunctival bevacizumab (avastin).
    Symes RJ; Poole TR
    Cornea; 2010 Jun; 29(6):691-3. PubMed ID: 20458243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subconjunctival injection of bevacizumab in the treatment of corneal neovascularization associated with lipid deposition.
    Chu HS; Hu FR; Yang CM; Yeh PT; Chen YM; Hou YC; Chen WL
    Cornea; 2011 Jan; 30(1):60-6. PubMed ID: 20847676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinico-biochemical correlation of the effect of subconjunctival bevacizumab for corneal neovascularization.
    Agarwal S; Angayarkanni N; Iyer G; Srinivasan B; Natarajan R; Charola S; Arumugam S; Padmanabhan P
    Cornea; 2014 Oct; 33(10):1016-21. PubMed ID: 25090164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subconjunctival bevacizumab injection for corneal neovascularization.
    Bahar I; Kaiserman I; McAllum P; Rootman D; Slomovic A
    Cornea; 2008 Feb; 27(2):142-7. PubMed ID: 18216566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of experimental corneal neovascularization by using subconjunctival injection of bevacizumab (Avastin).
    Kim TI; Kim SW; Kim S; Kim T; Kim EK
    Cornea; 2008 Apr; 27(3):349-52. PubMed ID: 18362666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.